Organon (OGN) Receivables - Other (2021 - 2023)

Organon has reported Receivables - Other for 3 years, with the latest figure at $344.0 million in Q1 2023.

• On a quarterly basis, Receivables - Other fell 3.91% year-over-year to $344.0 million in Q1 2023; TTM through Mar 2023 was $344.0 million, a 3.91% decrease from a year earlier, with the FY2022 full-year figure at $374.0 million, down 7.2% from the prior year.
• Receivables - Other was $344.0 million for Q1 2023 at Organon, down from $374.0 million in the prior quarter.
• The five-year high for Receivables - Other was $991.0 million in Q2 2021, with the low at $344.0 million in Q1 2023.
• Average Receivables - Other over 3 years is $528.8 million, with a median of $407.5 million recorded in 2021.
• The sharpest annual moves came in 2022 and 2023: Receivables - Other tumbled 56.21% in 2022, then slipped 3.91% in 2023.
• Over 3 years, Receivables - Other stood at $403.0 million in 2021, then dropped by 7.2% to $374.0 million in 2022, then retreated by 8.02% to $344.0 million in 2023.
• The last three Receivables - Other figures came in at $344.0 million (Q1 2023), $374.0 million (Q4 2022), and $412.0 million (Q3 2022), per Business Quant data.